PREFERRED PHARMACEUTICAL FORMULATIONS BY PATIENTS SUFFERING FROM SEXUAL DYSFUNCTION VISITING PSYCHIATRY OUT PATIENT DEPARTMENT IN AN TERTIARY CARE CENTER

Authors

  • Neha Shende Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India. https://orcid.org/0000-0003-1893-9684
  • Sharmada Nerlekar Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.
  • Abhilasha Rashmi Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India. https://orcid.org/0000-0002-7752-6698
  • sagar karia Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India. https://orcid.org/0000-0003-1555-5925
  • Sudhir Pawar Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i3.46778

Keywords:

sexual dysfunction, pharmaceutical formulation, ayurvedic, allopathy

Abstract

Objective: Sexual dysfunctions are increasing day by day. Various formulations are available for the treatment of same. There has been psychological mind-set among Indian patients to have powdered medicines for the sexual dysfunction management. The aim of this study was to analyze the preferred formulation by the patients for the treatment sexual dysfunction.

Methods: A cross-sectional and observational study was undertaken from January 2018–January 2019 in psychiatry OPD of a tertiary care teaching institute after approval from the Institutional Ethics Committee. A semi-structured questionnaire was made collecting information on demographic details and preferred pharmaceutical formulations for the treatment of sexual dysfunctions.

Results: Out of 164 participants who were analyzed, the most common age group having sexual dysfunctions was found to be 21–30 years (44%). Patients preferred Ayurvedic form of treatment (38.41%) over Allopathic (23.17%). Patients were in favor of SOS medications (51.83%) than day or night doses. Majority of the patients wanted drugs in tablet form (67.07%), in monthly doses (43.9%), of white color (39.02%), along with water (54.88%) and at <Rs.100 per strip (67.07%).

Conclusions: Majority of the patients prefer Ayurvedic form of treatment and SOS, on monthly basis, white colored tablets, taken with water at affordable prices. These factors need to be kept in mind while formulating new drugs and guidelines to ensure better compliance.

Downloads

Download data is not yet available.

Author Biography

Neha Shende, Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.

Resident Doctor, Department of Pharmacology, Lokmanya Tilak Municipal Medical College, Mumbai.

References

Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57. doi: 10.1038/sj.ijir.3901250, PMID 15215881

Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6. doi: 10.1046/j.1464- 410x.1999.00142.x, PMID 10444124

Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000;2:189-95. doi: 10.1007/s11920- 996-0006-2, PMID 11122954

Hackett GI. Patient preference in treatment of erectile dysfunction: The continuing importance of patient education. Clin Cornerstone 2005;7:57-65. doi: 10.1016/s1098-3597(05)80049-3, PMID 16156424

Sample Size Calculator-Confidence Level, Confidence Interval, Sample Size, Population Size, Relevant Population. Creative Research Systems. Available from: https://www.surveysystem.com/sscalc.htm

Verma R, Mina S, Ul-Hassan S, Balhara YP. A descriptive analysis of patients presenting to psychosexual clinic at a tertiary care center. Indian J Psychol Med 2013;35:241-7. doi: 10.4103/0253-7176.119473, PMID 24249924

Gupta SK, Dayal S, Jain VK, Kataria U, Relhan V. Profile of male patients presenting with psychosexual disorders. Indian J Sex Trans Dis 2004;25:33-7.

Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004;172:658-63. doi: 10.1097/01. ju.0000132389.97804.d7, PMID 15247755

Chauhan NS, Sharma V, Dixit VK, Thakur M. A review on plants used for improvement of sexual performance and virility. BioMed Res Int 2014;2014:868062. doi: 10.1155/2014/868062, PMID 25215296

Baldi A. Erectile dysfunction and ayurveda. J Res Educ Indian Med 2009;32:15-24.

Huang SA, Lie JD. Phosphodiesterase-5 (PDE-5) inhibitors in the management of erectile dysfunction. Pharm Ther 2013;38:407, 414-9.

Published

07-03-2023

How to Cite

Shende, N., S. Nerlekar, A. Rashmi, sagar karia, and S. Pawar. “PREFERRED PHARMACEUTICAL FORMULATIONS BY PATIENTS SUFFERING FROM SEXUAL DYSFUNCTION VISITING PSYCHIATRY OUT PATIENT DEPARTMENT IN AN TERTIARY CARE CENTER”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 3, Mar. 2023, pp. 81-83, doi:10.22159/ajpcr.2023.v16i3.46778.

Issue

Section

Original Article(s)